{"transactions":[{"id":1999947,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":116613,"kind":"person","name":"Smith Brendan","position":1,"cik":"0001857492","reported_name":"Smith Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-22T22:41:41.000Z","date":"2023-02-18","kind":"exercise","acquired":false,"shares":3825,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."}],"balance_after":11475,"derivative":{"underlying":"Common Shares","underlying_shares":3825},"source":{"system":"sec-edgar","filing":"0001209191-23-011790","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123011790/doc4.xml","form_type":"4"}},{"id":1999946,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":116613,"kind":"person","name":"Smith Brendan","position":1,"cik":"0001857492","reported_name":"Smith Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2023-02-22T22:41:41.000Z","date":"2023-02-21","kind":"tax_withholding","acquired":false,"shares":1392,"price":48.26,"value":67177.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":5072,"source":{"system":"sec-edgar","filing":"0001209191-23-011790","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123011790/doc4.xml","form_type":"4"}},{"id":1999945,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":116613,"kind":"person","name":"Smith Brendan","position":1,"cik":"0001857492","reported_name":"Smith Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2023-02-22T22:41:41.000Z","date":"2023-02-18","kind":"exercise","acquired":true,"shares":3825,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":6464,"source":{"system":"sec-edgar","filing":"0001209191-23-011790","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123011790/doc4.xml","form_type":"4"}},{"id":2135582,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":116613,"kind":"person","name":"Smith Brendan","position":1,"cik":"0001857492","reported_name":"Smith Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-10-18T21:38:29.000Z","date":"2022-10-14","kind":"exercise","acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restriced stock units shall vest as follows: (i) one quarter of the shares shall vest on October 14, 2022, (ii) one quarter of the shares shall vest on October 14, 2023, (iii) one quarter of the shares shall vest on October 14, 2024, and (iv) one quarter of the shares shall vest on October 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restriced stock units shall vest as follows: (i) one quarter of the shares shall vest on October 14, 2022, (ii) one quarter of the shares shall vest on October 14, 2023, (iii) one quarter of the shares shall vest on October 14, 2024, and (iv) one quarter of the shares shall vest on October 14, 2025."}],"balance_after":11250,"derivative":{"underlying":"Common Shares","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001209191-22-053989","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122053989/doc4.xml","form_type":"4"}},{"id":2135581,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":116613,"kind":"person","name":"Smith Brendan","position":1,"cik":"0001857492","reported_name":"Smith Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2022-10-18T21:38:29.000Z","date":"2022-10-17","kind":"tax_withholding","acquired":false,"shares":1111,"price":55.76,"value":61949.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On October 14, 2021, the reporting person was granted 15,000 restricted stock units. On October 14, 2022, 3,750 restricted stock units vested. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":2639,"source":{"system":"sec-edgar","filing":"0001209191-22-053989","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122053989/doc4.xml","form_type":"4"}},{"id":2135580,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":116613,"kind":"person","name":"Smith Brendan","position":1,"cik":"0001857492","reported_name":"Smith Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2022-10-18T21:38:29.000Z","date":"2022-10-14","kind":"exercise","acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restriced stock units shall vest as follows: (i) one quarter of the shares shall vest on October 14, 2022, (ii) one quarter of the shares shall vest on October 14, 2023, (iii) one quarter of the shares shall vest on October 14, 2024, and (iv) one quarter of the shares shall vest on October 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":3750,"source":{"system":"sec-edgar","filing":"0001209191-22-053989","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122053989/doc4.xml","form_type":"4"}},{"id":2138323,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":116613,"kind":"person","name":"Smith Brendan","position":1,"cik":"0001857492","reported_name":"Smith Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-12T21:42:57.000Z","date":"2022-10-07","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on October 7, 2022 with respect to 14,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 7, 2022."}],"balance_after":14000,"derivative":{"exercise_price":61.65,"expiration_date":"2032-10-07","underlying":"Common Shares","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-22-053498","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122053498/doc4.xml","form_type":"4"}},{"id":2179555,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":116613,"kind":"person","name":"Smith Brendan","position":1,"cik":"0001857492","reported_name":"Smith Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-08-18T21:39:09.000Z","date":"2022-08-16","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in full on February 16, 2025, subject to continued service to the Company or any of its subsidiaries."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in full on February 16, 2025, subject to continued service to the Company or any of its subsidiaries."}],"balance_after":10000,"derivative":{"underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-22-046714","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122046714/doc4.xml","form_type":"4"}},{"id":2382262,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":116613,"kind":"person","name":"Smith Brendan","position":1,"cik":"0001857492","reported_name":"Smith Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-22T22:44:06.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":15300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."}],"balance_after":15300,"derivative":{"underlying":"Common Shares","underlying_shares":15300},"source":{"system":"sec-edgar","filing":"0001209191-22-011841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122011841/doc4.xml","form_type":"4"}},{"id":2382261,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":116613,"kind":"person","name":"Smith Brendan","position":1,"cik":"0001857492","reported_name":"Smith Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-22T22:44:06.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 18, 2022 with respect to 30,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of March 18, 2022."}],"balance_after":30000,"derivative":{"exercise_price":58.29,"expiration_date":"2032-02-18","underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-22-011841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122011841/doc4.xml","form_type":"4"}},{"id":2540580,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":116613,"kind":"person","name":"Smith Brendan","position":1,"cik":"0001857492","reported_name":"Smith Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-19T00:00:39.000Z","date":"2021-10-14","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on October 14, 2021 with respect to 90,000 Common Shares, with 25% of the shares vesting on October 14, 2022 and the remaining shares vesting on each monthly anniversary thereafter for a period of 36 months."}],"balance_after":90000,"derivative":{"exercise_price":98.7,"expiration_date":"2031-10-14","underlying":"Common Shares","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-21-060777","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121060777/doc4.xml","form_type":"4"}},{"id":2540579,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":116613,"kind":"person","name":"Smith Brendan","position":1,"cik":"0001857492","reported_name":"Smith Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-10-19T00:00:39.000Z","date":"2021-10-14","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This restricted stock unit award was granted on October 14, 2021 with respect to 15,000 Common Shares, with (i) one quarter of the shares vesting on October 14, 2022, (ii) one quarter of the shares vesting on October 14, 2023, (iii) one quarter of the shares vesting on October 14, 2024, and (iv) one quarter of the shares vesting on October 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This restricted stock unit award was granted on October 14, 2021 with respect to 15,000 Common Shares, with (i) one quarter of the shares vesting on October 14, 2022, (ii) one quarter of the shares vesting on October 14, 2023, (iii) one quarter of the shares vesting on October 14, 2024, and (iv) one quarter of the shares vesting on October 14, 2025."}],"balance_after":15000,"derivative":{"underlying":"Common Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-060777","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121060777/doc4.xml","form_type":"4"}},{"id":2570844,"issuer":{"id":135439,"kind":"organization","name":"Translate Bio, Inc.","symbol":"TBIO"},"owners":[{"id":116613,"kind":"person","name":"Smith Brendan","position":1,"cik":"0001857492","reported_name":"Smith Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stcok Option (right to buy)","published_at":"2021-09-14T19:33:46.000Z","date":"2021-09-14","kind":"sale","acquired":false,"shares":201800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As of September 14, 2021, Issuer was acquired in a cash tender by an indirect subsidiary of Sanofi, a French societe anonyme at a purchase price of $38.00 per share (the \"Tender Offer\"), as described more fully in the Schedule 14D-9 filed by the Issuer on August 16, 2021.  Under the terms of the Tender Offer, Issuer outstanding stock options, if not vested became vested, and all Issuer stock options were converted into cash consideration at the amount of the difference between the exercise price of the option and the Tender Offer price of $38.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on April 19, 2021.  The shares underlying this option are scheduled to vest over four years, with 25% of the shares vesting on April 19, 2022 and the remainder vesting in equal monthly installments through April 19, 2025."}],"balance_after":0,"derivative":{"exercise_price":19.23,"expiration_date":"2031-04-18","underlying":"Common Stock","underlying_shares":201800},"source":{"system":"sec-edgar","filing":"0001209191-21-056064","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693415/000120919121056064/doc4.xml","form_type":"4"}},{"id":2744026,"issuer":{"id":135439,"kind":"organization","name":"Translate Bio, Inc.","symbol":"TBIO"},"owners":[{"id":116613,"kind":"person","name":"Smith Brendan","position":1,"cik":"0001857492","reported_name":"Smith Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-20T16:49:58.000Z","date":"2021-04-19","kind":"grant","acquired":true,"shares":201800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on April 19 2021.  The shares underlying the option are scheduled to vest over four years, with 25% of the shares vesting on April 19, 2022 and the remainder vesting in equal monthly installments through April 19, 2025."}],"balance_after":201800,"derivative":{"exercise_price":19.23,"expiration_date":"2031-04-18","underlying":"Common Stock","underlying_shares":201800},"source":{"system":"sec-edgar","filing":"0000899243-21-016406","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693415/000089924321016406/doc4.xml","form_type":"4"}}]}